Impact of a clonal outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in the development and evolution of bloodstream infections by K. pneumoniae and Escherichia coli: An 11 year experience in Oxfordshire, Uk

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 9, 2011, Pages 2126-2135

  Webster, D P ^a   Young, B C ^b   Morton, R ^b   Collyer, D ^b   Batchelor, B ^b   Turton, J F ^c   Maharjan, S ^c   Livermore, D M ^c   Bejon, P ^b   Cookson, B D ^c   Bowler, I C J W ^b  

^a BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

^b OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

ESBLs; MDR; Multidrug resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BETA LACTAMASE CTX M; CEFTAZIDIME; CEFTRIAXONE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; TRIMETHOPRIM;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CLONE; CONTROLLED STUDY; EPIDEMIC; ESCHERICHIA COLI INFECTION; FEMALE; GENE SEQUENCE; HUMAN; INFECTION RISK; KLEBSIELLA PNEUMONIAE; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; RETROSPECTIVE STUDY; RISK ASSESSMENT; UNITED KINGDOM; URINE CULTURE;

ADULT; AGED; AGED, 80 AND OVER; BETA-LACTAMASES; CASE-CONTROL STUDIES; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GREAT BRITAIN; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80051700999     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr246     Document Type: Article

References (31)

1. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005; 18: 657-86.
2. Livermore DM, Hope R, Brick G et al. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001- 06. J Antimicrob Chemother 2008; 62 Suppl 2: ii41-54.
3. Schwaber MJ, Navon-Venezia S, Schwartz D et al. High levels of antimicrobial coresistance among extended-spectrum-β-lactamaseproducing Enterobacteriaceae. Antimicrob Agents Chemother 2005; 49: 2137-9.
4. Paterson DL, Ko WC, Von Gottberg A et al. Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum β-lactamases. Clin Infect Dis 2004; 39: 31-7.
5. Falagas ME, Karageorgopoulos DE. Extended-spectrum β-lactamase-producing organisms. J Hosp Infect 2009; 73: 345-54.
6. Schwaber MJ, Navon-Venezia S, Kaye KS et al. Clinical and economic impact of bacteremia with extended-spectrum-β-lactamase-producing Enterobacteriaceae. Antimicrob Agents Chemother 2006; 50: 1257-62.
7. Ramphal R, Ambrose PG. Extended-spectrum β-lactamases and clinical outcomes: current data. Clin Infect Dis 2006; 42 Suppl 4: S164-72.
8. Marra AR, Wey SB, Castelo A et al. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis 2006; 6: 24.
9. Mosqueda-Gomez JL, Montano-Loza A, Rolon AL et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae: a case-control study. Int J Infect Dis 2008; 12: 653-9.
10. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 60: 913-20.
11. Ortega M, Marco F, Soriano A et al. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J Antimicrob Chemother 2009; 63: 568-74.
12. Rodriguez-Bano J, Picon E, Gijon P et al. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-β-lactamase-producing Escherichia coli. J Clin Microbiol 2010; 48: 1726-31.
13. Tumbarello M, Sanguinetti M, Montuori E et al. Predictors of mortality in patients with bloodstream infections caused by extendedspectrum-β-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob Agents Chemother 2007; 51: 1987-94.
14. Kang CI, Kim SH, Park WB et al. Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob Agents Chemother 2004; 48: 4574-81.
15. Chaubey VP, Pitout JD, Dalton B et al. Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum β-lactamase producing Escherichia coli and Klebsiella pneumoniae. BMC Res Notes 2010; 3: 116.
16. Mendelson G, Hait V, Ben-Israel J et al. Prevalence and risk factors of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis 2005; 24: 17-22.
17. Paterson DL, Ko WC, Von Gottberg A et al. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum β-lactamase production in nosocomial infections. Ann Intern Med 2004; 140: 26-32.
18. Graffunder EM, Preston KE, Evans AM et al. Risk factors associated with extended-spectrum β-lactamase-producing organisms at a tertiary care hospital. J Antimicrob Chemother 2005; 56: 139-45.
19. Mangeney N, Niel P, Paul G et al. A 5-year epidemiological study of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates in a medium- and long-stay neurological unit. J Appl Microbiol 2000; 88: 504-11.
20. de Champs C, Sirot D, Chanal C et al. Concomitant dissemination of three extended-spectrum β-lactamases among different Enterobacteriaceae isolated in a French hospital. J Antimicrob Chemother 1991; 27: 441-57.
21. D'Agata E, Venkataraman L, DeGirolami P et al. The molecular and clinical epidemiology of Enterobacteriaceae producing extended-spectrum β-lactamase in a tertiary care hospital. J Infect 1998; 36: 279-85.
22. Wiener J, Quinn JP, Bradford PA et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 1999; 281: 517-23.
23. Wyllie DH, Peto TE, Crook D. MRSA bacteraemia in patients on arrival in hospital: a cohort study in Oxfordshire 1997-2003. BMJ 2005; 331: 992.
24. Brown DF, Kothari D. Antimicrobial-susceptibility testing of rapidly growing pathogenic bacteria. II. A field trial of four disc-diffusion methods. J Antimicrob Chemother 1978; 4: 27-38.
25. Heym B, Lacroix O, Pean Y et al. Use of cefotaxime or ceftazidime susceptibility tests for predicting susceptibility of Enterobacteriaceae and Pseudomonas aeruginosa. J Antimicrob Chemother 1994; 33: 729-35.
26. Standards Unit CfI. Health Protection Agency. UK: Investigation of Urine. http://www.hpa-standardmethods.org.uk/documents/bsop/pdf/ bsop41.pdf (9 June 2011, date last accessed).
27. Diancourt L, Passet V, Verhoef J et al. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J Clin Microbiol 2005; 43: 4178-82.
28. Poirel L, Gniadkowski M, Nordmann P. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum b-lactamase CTX-M-15 and of its structurally related b-lactamase CTX-M-3. J Antimicrob Chemother 2002; 50: 1031-4.
29. Lau SH, Kaufmann ME, Livermore DM et al. UK epidemic Escherichia coli strains A-E, with CTX-M-15 b-lactamase, all belong to the international O25:H4-ST131 clone. J Antimicrob Chemother 2008; 62: 1241-4.
30. Garner JS, Jarvis WR, Emori TG et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-40.
31. Christian NA, Roye-Green K, Smikle M. Molecular epidemiology of multidrug resistant extended-spectrum b-lactamase producing Klebsiella pneumoniae at a Jamaican hospital, 2000-2004. BMC Microbiol 2010; 10: 27.